Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-07-17

FDA Approved: PHENELZINE SULFATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' supplemental application for Phenelzine sulfate (ANDA 200181), a generic monoamine oxidase inhibitor used for depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenelzine sulfate (Phenelzine sulfate)

Snippet

SUPPL AP for PHENELZINE SULFATE (PHENELZINE SULFATE)